| dc.contributor.author | SOBOLEWSKA, Bianka | |
| dc.contributor.author | BAARSMA, Seerp | |
| dc.contributor.author | HOYNG, Carel | |
| dc.contributor.author | CORDERO-COMA, Miguel | |
| dc.contributor.author | Tomkins-Netzer, Oren | |
| dc.contributor.author | ROZALSKI, Anna | |
| dc.contributor.author | Guex-Crosier, Yan | |
| dc.contributor.author | LOS, Leonoor I. | |
| dc.contributor.author | BOLLEMEIJER, Jan Geert | |
| dc.contributor.author | NOLAN, Andrew | |
| dc.contributor.author | PAWADE, Joya | |
| dc.contributor.author | Willermain, Francois | |
| dc.contributor.author | BODAGHI, Bahram | |
| dc.contributor.author | ten Dam-van Loon, Ninette | |
| dc.contributor.author | DICK, Andrew | |
| dc.contributor.author | ZIERHUT, Manfred | |
| dc.contributor.author | Lightman, Susan | |
| dc.contributor.author | MACKENSEN, Friederike | |
| dc.contributor.author | Moulin, Alexandre | |
| dc.contributor.author | Tugal-Tutkun, Ilknur | |
| dc.contributor.author | LE HOANG, Phuc | |
| dc.contributor.author | Erckens, Roel | |
| dc.contributor.author | MISSOTTEN, Tom | |
| dc.contributor.author | WENSING, Barbara | |
| dc.contributor.author | Lokhorst, Henk | |
| dc.contributor.author | ROTHOVA, Aniki | |
| dc.contributor.author | Riemens, Anjo | |
| dc.contributor.author | BROMBERG, Jacoline | |
| dc.contributor.author | TOUITOU, Valerie | |
| dc.date.accessioned | 2021-03-03T21:00:05Z | |
| dc.date.available | 2021-03-03T21:00:05Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Riemens A., BROMBERG J., TOUITOU V., SOBOLEWSKA B., MISSOTTEN T., BAARSMA S., HOYNG C., CORDERO-COMA M., Tomkins-Netzer O., ROZALSKI A., et al., "Treatment Strategies in Primary Vitreoretinal Lymphoma A 17-Center European Collaborative Study", JAMA OPHTHALMOLOGY, cilt.133, sa.2, ss.191-197, 2015 | |
| dc.identifier.issn | 2168-6165 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_5ce7e399-ba52-49de-a12a-0e312ed3a8ce | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/65093 | |
| dc.identifier.uri | https://doi.org/10.1001/jamaophthalmol.2014.4755 | |
| dc.description.abstract | IMPORTANCE The best treatment option for primary vitreoretinal lymphoma (PVRL) without signs of central nervous system lymphoma (CNSL) involvement determined on magnetic resonance imaging or in cerebrospinal fluid is unknown. | |
| dc.language.iso | eng | |
| dc.subject | OFTALMOLOJİ | |
| dc.subject | Göz Hastalıkları ve Cerrahisi | |
| dc.subject | Cerrahi Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.title | Treatment Strategies in Primary Vitreoretinal Lymphoma A 17-Center European Collaborative Study | |
| dc.type | Makale | |
| dc.relation.journal | JAMA OPHTHALMOLOGY | |
| dc.contributor.department | Universiteit Utrecht (University College Utrecht) , , | |
| dc.identifier.volume | 133 | |
| dc.identifier.issue | 2 | |
| dc.identifier.startpage | 191 | |
| dc.identifier.endpage | 197 | |
| dc.contributor.firstauthorID | 25044 | |